February 18, 2022, Sheridan, WY — Ageless Biotech, Inc., a biotech company created to bring stem cell-based therapeutics to market, has acquired a U.S. Food and Drug Administration (FDA) Investigational New Drug Application (IND) for the treatment of Osteoarthritis of the Knee.
The Arthritis Foundation has described Osteoarthritis as a “chronic disease … with no cure.” Over a decade ago in 2009 ABC News published, medical care for osteoarthritis patients in the United States costs $185.5 billion a year.1 [Read more…]
